Reinforcing the Induction of Immunogenic Cell Death Via Artificial Engineered Cascade Bioreactor‐Enhanced Chemo‐Immunotherapy for Optimizing Cancer Immunotherapy
出版年份 2021 全文链接
标题
Reinforcing the Induction of Immunogenic Cell Death Via Artificial Engineered Cascade Bioreactor‐Enhanced Chemo‐Immunotherapy for Optimizing Cancer Immunotherapy
作者
关键词
-
出版物
Small
Volume 17, Issue 37, Pages 2101897
出版商
Wiley
发表日期
2021-08-07
DOI
10.1002/smll.202101897
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Gold nanoparticles doped metal-organic frameworks as near-infrared light-enhanced cascade nanozyme against hypoxic tumors
- (2020) Xinli Liu et al. Nano Research
- Nanoenabled Disruption of Multiple Barriers in Antigen Cross-Presentation of Dendritic Cells via Calcium Interference for Enhanced Chemo-Immunotherapy
- (2020) Jingyi An et al. ACS Nano
- Multifunctional Nanoparticle Loaded Injectable Thermoresponsive Hydrogel as NIR Controlled Release Platform for Local Photothermal Immunotherapy to Prevent Breast Cancer Postoperative Recurrence and Metastases
- (2020) Yan Peng Jia et al. ADVANCED FUNCTIONAL MATERIALS
- Improving Cancer Immunotherapy Outcomes using Biomaterials
- (2020) Xiaogang Liu et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Mimetic Heat Shock Protein Mediated Immune Process to Enhance Cancer Immunotherapy
- (2020) Xue Li et al. NANO LETTERS
- Nanocarrier-mediated immunogenic chemotherapy for triple negative breast cancer
- (2020) Yun Liu et al. JOURNAL OF CONTROLLED RELEASE
- Eliciting Immunogenic Cell Death via a Unitized Nanoinducer
- (2020) Zan Dai et al. NANO LETTERS
- Nanoscale Metal–Organic Frameworks for Cancer Immunotherapy
- (2020) Kaiyuan Ni et al. ACCOUNTS OF CHEMICAL RESEARCH
- Smart Porous Core–Shell Cuprous Oxide Nanocatalyst with High Biocompatibility for Acid‐Triggered Chemo/Chemodynamic Synergistic Therapy
- (2020) Hongshuai Wu et al. Small
- Carrier-free nanoassembly of doxorubicin prodrug and siRNA for combinationally inducing immunogenic cell death and reversing immunosuppression
- (2020) Senbiao Chen et al. Nano Today
- Nanoparticle-Enhanced Radiotherapy to Trigger Robust Cancer Immunotherapy
- (2019) Qian Chen et al. ADVANCED MATERIALS
- Tumor Microenvironment‐Triggered Aggregated Magnetic Nanoparticles for Reinforced Image‐Guided Immunogenic Chemotherapy
- (2019) Qinjun Chen et al. Advanced Science
- In Situ Dendritic Cell Vaccine for Effective Cancer Immunotherapy
- (2019) Weijing Yang et al. ACS Nano
- Immunity, Hypoxia and Metabolism - the ménage à trois of cancer: implications for immunotherapy
- (2019) Carla Riera-Domingo et al. PHYSIOLOGICAL REVIEWS
- Enhancing Triple Negative Breast Cancer Immunotherapy by ICG‐Templated Self‐Assembly of Paclitaxel Nanoparticles
- (2019) Bing Feng et al. ADVANCED FUNCTIONAL MATERIALS
- A Multifunctional Cascade Bioreactor Based on Hollow‐Structured Cu 2 MoS 4 for Synergetic Cancer Chemo‐Dynamic Therapy/Starvation Therapy/Phototherapy/Immunotherapy with Remarkably Enhanced Efficacy
- (2019) Mengyu Chang et al. ADVANCED MATERIALS
- Intra/Extracellular Lactic Acid Exhaustion for Synergistic Metabolic Therapy and Immunotherapy of Tumors
- (2019) Fan Gao et al. ADVANCED MATERIALS
- Artificial Enzyme Catalyzed Cascade Reactions: Antitumor Immunotherapy Reinforced by NIR-II Light
- (2019) Mei Wen et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Simultaneous Fenton-like Ion Delivery and Glutathione Depletion by MnO2 -Based Nanoagent to Enhance Chemodynamic Therapy
- (2018) Li-Sen Lin et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Synergistic and low adverse effect cancer immunotherapy by immunogenic chemotherapy and locally expressed PD-L1 trap
- (2018) Wantong Song et al. Nature Communications
- Elimination of established tumors with nanodisc-based combination chemoimmunotherapy
- (2018) Rui Kuai et al. Science Advances
- Nanoparticle-mediated HMGA1 Silencing Promotes Lymphocyte Infiltration and Boosts Checkpoint Blockade Immunotherapy for Cancer
- (2018) Ying Wang et al. ADVANCED FUNCTIONAL MATERIALS
- Enhanced highly toxic reactive oxygen species levels from iron oxide core–shell mesoporous silica nanocarrier-mediated Fenton reactions for cancer therapy
- (2018) Kai Sun et al. Journal of Materials Chemistry B
- Nanocatalytic Tumor Therapy by Biomimetic Dual Inorganic Nanozyme-Catalyzed Cascade Reaction
- (2018) Shanshan Gao et al. Advanced Science
- Cell death and immunity in cancer: From danger signals to mimicry of pathogen defense responses
- (2017) Abhishek D. Garg et al. IMMUNOLOGICAL REVIEWS
- Acid-Responsive Polymeric Doxorubicin Prodrug Nanoparticles Encapsulating a Near-Infrared Dye for Combined Photothermal-Chemotherapy
- (2016) Yuanyuan Zhang et al. CHEMISTRY OF MATERIALS
- Regular Aspirin Use Associates With Lower Risk of Colorectal Cancers With Low Numbers of Tumor-Infiltrating Lymphocytes
- (2016) Yin Cao et al. GASTROENTEROLOGY
- “Manganese Extraction” Strategy Enables Tumor-Sensitive Biodegradability and Theranostics of Nanoparticles
- (2016) Luodan Yu et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Cyclooxygenase-Dependent Tumor Growth through Evasion of Immunity
- (2015) Santiago Zelenay et al. CELL
- Aspirin Suppresses the Growth and Metastasis of Osteosarcoma through the NF- B Pathway
- (2015) D. Liao et al. CLINICAL CANCER RESEARCH
- Positive feedback between PGE2 and COX2 redirects the differentiation of human dendritic cells toward stable myeloid-derived suppressor cells
- (2011) N. Obermajer et al. BLOOD
- Regulation of Immune Responses by Prostaglandin E2
- (2011) P. Kalinski JOURNAL OF IMMUNOLOGY
- Intracellular Glutathione Detection Using MnO2-Nanosheet-Modified Upconversion Nanoparticles
- (2011) Renren Deng et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Self-Catalyzed, Self-Limiting Growth of Glucose Oxidase-Mimicking Gold Nanoparticles
- (2010) Weijie Luo et al. ACS Nano
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More